Mark V. Anquillare Purchases 2,500 Shares of TruBridge, Inc. (NASDAQ:TBRG) Stock

TruBridge, Inc. (NASDAQ:TBRG) Director Mark V. Anquillare purchased 2,500 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was bought at an average price of $16.81 per share, with a total value of $42,025.00. Following the acquisition, the director now owns 17,178 shares in the company, valued at $288,762.18. This trade represents a 17.03 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

TruBridge Price Performance

NASDAQ:TBRG opened at $16.93 on Wednesday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.78 and a current ratio of 1.80. The company has a market capitalization of $252.76 million, a price-to-earnings ratio of -4.12, a price-to-earnings-growth ratio of 36.76 and a beta of 0.61. TruBridge, Inc. has a one year low of $7.55 and a one year high of $17.42. The stock has a 50-day simple moving average of $13.33 and a 200 day simple moving average of $11.73.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in TBRG. GAMMA Investing LLC bought a new position in TruBridge during the third quarter worth $26,000. Covestor Ltd bought a new position in shares of TruBridge in the 3rd quarter worth about $28,000. First Horizon Advisors Inc. bought a new stake in shares of TruBridge during the 3rd quarter valued at about $33,000. Point72 DIFC Ltd acquired a new stake in TruBridge during the second quarter worth about $56,000. Finally, FMR LLC bought a new position in TruBridge in the third quarter worth about $85,000. Institutional investors and hedge funds own 88.64% of the company’s stock.

Analyst Upgrades and Downgrades

TBRG has been the subject of a number of recent analyst reports. Barclays raised their price target on shares of TruBridge from $10.00 to $14.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Stephens lifted their target price on TruBridge from $13.00 to $17.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 20th. Royal Bank of Canada reissued an “outperform” rating and issued a $14.00 price target on shares of TruBridge in a report on Tuesday, September 17th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $13.00 target price on shares of TruBridge in a research report on Friday, October 4th.

TruBridge Company Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.